Comparative Pharmacology
Head-to-head clinical analysis: LORCET HD versus TYCOLET.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LORCET HD versus TYCOLET.
LORCET-HD vs TYCOLET
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydrocodone is a mu-opioid receptor agonist, modulating pain perception and emotional response to pain. Acetaminophen inhibits cyclooxygenase (COX) and modulates descending serotonergic pathways, providing antipyretic and analgesic effects.
Acetaminophen: COX-1/COX-2 inhibitor in CNS; Paracetamol: analgesic and antipyretic via central inhibition of prostaglandin synthesis.
1-2 tablets (hydrocodone 5-10 mg / acetaminophen 325-650 mg) orally every 4-6 hours as needed for pain; maximum acetaminophen 4 g/day (or 3 g/day in at-risk patients).
500-1000 mg orally or intravenously every 4-6 hours, maximum 4 g/day.
None Documented
None Documented
Morphine: 2-4 hours; hydrocodone: 3.8-6 hours. Clinical context: Immediate-release, dosing every 4-6 hours.
Terminal elimination half-life is 2-4 hours; prolonged in renal impairment (up to 12-24 hours in ESRD).
Renal: 90% as morphine-3-glucuronide and morphine-6-glucuronide, 10% as unchanged morphine; biliary: minor (<5%); fecal: <5%.
Renal: 70-80% unchanged; Biliary/fecal: 10-15% as metabolites.
Category C
Category C
Opioid analgesic combination
Opioid analgesic combination